Market Size of Artificial Kidney Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 12.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Artificial Kidney Market Analysis
The artificial kidney market is expected to register a CAGR of 12.2% over the forecast period.
The artificial kidney market was significantly impacted during the COVID-19 pandemic due to a decline in kidney transplant activities across the world. According to the study published in Transplantation in June 2022, during COVID-19, there was a 16% global decrease in transplant activity, with kidney transplants being the most affected. Thus, a decline in kidney transplants may positively influence the artificial kidney market. Moreover, the initial phase of the pandemic hampered the supply chain of medical devices, including artificial kidneys. However, the market has huge potential to grow over the projected period due to the scarcity of kidney donors across the world.
The studied market is expected to grow owing to the prevalence of chronic kidney diseases, the scarcity of donors, and technological advances in artificial kidneys.
The growing burden of chronic diseases such as chronic kidney diseases, end-stage renal diseases, and kidney failure may drive the demand for artificial kidneys, as artificial kidneys are designed to work like the natural kidney, filtering the blood and maintaining the body's fluid balance. For instance, as per the article published in the journal Kidney International Supplements in April 2022, chronic kidney disease, a progressive condition, has affected over 10% of the general population worldwide to date, accounting for more than 800 million individuals. The large volume of the population affected by kidney diseases in the world is likely to contribute to the growth of the artificial kidney market over the forecast period.
The scarcity of kidney donors is expected to increase the demand for artificial kidneys for effective health management. For instance, according to the Kidney Foundation Funds Data published in 2022, there are more than 90,000 Americans on the kidney transplant waiting list, but just 26,309, or nearly one in every four, will receive a kidney transplant in 2022. This indicates a huge scarcity of donors for kidney transplants, and thus, it is expected to boost the artificial kidney market over the forecast period.
Another factor is the introduction of technologically advanced products like low-maintenance dialysis equipment and artificial kidneys. In March 2021, Baxter International Inc. announced the United States FDA clearance of its next-generation Artificial Kidney 98 dialysis machine, designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments. This indicated that companies are taking initiatives to establish a strong footprint and launch technologically advanced products in the market. The product launches also propel the growth of the market. For instance, in December 2021, FMS announced the release of the FX CorAL, a new hemodialysis dialyzer in the company's FX class of dialyzers that uses polysulfone (a unique plastic with superior filtering and hemocompatibility features).
Thus, all of the aforementioned variables, such as the rising incidence of chronic renal illnesses, the paucity of kidney transplant donors, and market leaders' strategic actions, are projected to drive market growth. However, the high cost associated with artificial kidneys may restrain market growth.
